ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 955,41
0,51%
Dow Jones
38 225,66
0,00%
DAX
17 961,68
0,31%
Brent Oil
84,145
0,62%
Bitcoin
59 103,57
-0,03%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Apellis Pharmaceuticals Inc (APLS)

  7. Apellis Pharmaceuticals Inc (APLS) Actualités

APLS Apellis Pharmaceuticals Inc

47,49
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:06:16
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Apellis Pharmaceuticals Inc APLS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 47,49 13:06:16
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
47,49
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202413:00GLOBEApellis Announces 11 Oral Presentations at the Association..
26/4/202413:15GLOBEApellis Announces Pegcetacoplan MAA Review Has Been Reset to..
23/4/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on May 7,..
04/4/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/4/202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
11/3/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202412:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
08/3/202422:10EDGAR2Form 144 - Report of proposed sale of securities
08/3/202413:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202419:37EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/2/202413:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202413:30EDGAR2Form 8-K - Current report
27/2/202413:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27/2/202413:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202413:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20/2/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
14/2/202423:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202421:46EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:43EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:28EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:27EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:22EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:19EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
31/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202416:50EDGAR2Form 144 - Report of proposed sale of securities
30/1/202416:04EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:22EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés